
Venture capital · Early to growth stage · Est. 2012
Decheng Capital
Decheng Capital is a life sciences investment firm with offices in Silicon Valley and Shanghai. It backs early-stage life science ventures and growth-stage healthcare companies worldwide.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Decheng Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Decheng Capital joined, from press and the firm’s own posts.
Every round Decheng Capital joined
Round sizes, Decheng Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Decheng Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Decheng Capital
Events where Decheng Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Decheng Capital is based in Menlo Park, United States. It also has an office in Shanghai.
In 2012.
8 fund vehicles are on public registers (SEC adviser filings), including DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND IV, L.P., DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND III, L.P. and DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND II, L.P.
Stages: Early stage, Growth. Sectors: Life sciences. From the firm’s own website.
Decheng Capital lists 72 portfolio companies on its website, including 3SBio, Aadi, Accuragen, ACELYRIN and Adaptive Biotechnologies.
Firms whose websites list some of the same companies include Foresite Capital, Biomatics Capital and Longitude Capital.
Know before Decheng Capital’s next round is announced.
PRO tracks Decheng Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.